Cerevel Therapeutics Holdings, Inc.
CEREDelisted Aug 1, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001805387
Cerevel Therapeutics Holdings, Inc. was delisted on Aug 1, 2024; its insiders filed their last Form 4 on Aug 5, 2024; 231 institutions reported holding it in 13F filings for Q2 2024, worth $6.42B in total; Soros Fund Management was the only superinvestor holding it.
Holders of 5% or more of CERE
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Cerevel Therapeutics Holdings, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Cerevel Therapeutics Holdings, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Cerevel Therapeutics Holdings, Inc., newest first.
No Schedule 13D or 13G filings on Cerevel Therapeutics Holdings, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Cerevel Therapeutics Holdings, Inc. shares.
No Form 144 notices for Cerevel Therapeutics Holdings, Inc. are on file.